Viemed Healthcare, Inc. (VMD) Fair Value 2026

VMD · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.2 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-08-28, Viemed Healthcare, Inc. (VMD) trades at $8.82, versus a $4.92 median fair value across its 12 active models — 44.2% below the current price. QOC: 8.2/10. Value Trap Risk: 19/100 (SAFE). 12/13 models active. Within that set, the Bayesian DCF component alone returns $3.56.

Key Facts

Ticker
VMD
Price
$8.82
Quality Score
8.2/10
Value Trap Risk
19/100
Models Active
12/13
Last Updated
Strength: First Chicago suggests +202.1% upside with 60% confidence
Risk: Majority of models suggest overvaluation

Is Viemed Healthcare, Inc. (VMD) Undervalued or Overvalued in 2026?

According to CirclFi’s 12-model valuation engine, Viemed Healthcare, Inc. (VMD) appears overvalued as of : the median of 12 independent fair value estimates is $4.92, 44.2% below the current price of $8.82. Estimates range from $1.46 to $26.64. VMD scores 8.2/10 on fundamental quality and 19/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. VMD’s -44.2% gap is wider than that market norm, and the Medical Devices sector median is -43.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Viemed Healthcare, Inc. Stock in 2026? →

What Fair Value Does Each Model Give VMD?

12 Intrinsic Value Models vs. Current Price ($8.82)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $3.56 -59.6%
Intrinsic · High Conviction
 $3.93 -55.4%
Ensemble · Low Conviction
 $6.02 -31.7%
Scenario · High Conviction
 $26.64 +202.1%
Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is VMD's Fair Value Range?

Spread across 12 independent models · $1.46 to $26.64

CirclFi's 12 active models place Viemed Healthcare, Inc. (VMD) between $1.46 and $26.64 per share, a spread of 511% of the median. The median of that range — $4.92 — is the fair value CirclFi publishes for VMD, against a current price of $8.82.

Low · Dynamic NAVHigh · First Chicago
$1.46median $4.92$26.64
Where the range comes from
Most bearish modelDynamic NAV$1.46
Most bullish modelFirst Chicago$26.64
Model agreement4 bullish · 8 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for VMD. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on VMD, not a CirclFi price target. How each model works →

What Is Viemed Healthcare, Inc. (VMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Viemed Healthcare, Inc. at its current price of $8.82. The median intrinsic value is estimated at $4.92 (-44.2% vs price), with 8 models flagging overvaluation risk. The most optimistic model, First Chicago, places fair value at $26.64 (+202.1%), while Dynamic NAV — the most conservative — estimates $1.46 (-83.4%). This +285.5% gap reflects genuine analytical uncertainty about Viemed Healthcare, Inc.'s intrinsic worth.

What Do the Models Say About VMD?

12 of 13 models are currently active for VMD. Of these, 4 models suggest upside while 8 models suggest overvaluation. Taken together, their median fair value for VMD is $4.92 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $3.56 on its own, implying -59.6% downside from the current price. See which stocks rank higher →

How Does VMD Rank in Medical Devices?

Among 159 Medical Devices stocks, VMD ranks #27 by Quality of Company score. CirclFi's QOC score of 8.2/10 evaluates 32 fundamental signals. A score of 8.2 places VMD in the top tier.

See all Most Undervalued Medical Devices Stocks →

As a pharmaceutical industry, Viemed Healthcare, Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating VMD should weigh these sector-specific dynamics alongside our model-derived fair values.

Is VMD a Value Trap?

CirclFi's Value Trap algorithm assigns VMD a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Viemed Healthcare, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Viemed Healthcare, Inc. is rated at 8.2/10. This strong-tier score demonstrates strong fundamentals across the majority of our quality signals.

The gap between the most bullish and bearish model spans +285.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every VMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across VMD's 12 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Viemed Healthcare, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ITGRInteger Holdings CorporationQOC 8.2LIVNLivaNova PLCQOC 8.1BVSBioventus Inc.QOC 8.2INFUInfuSystem Holdings, Inc.QOC 8.1MDNCMedinotec Inc.QOC 8.2GEHCGE HealthCare Technologies Inc.QOC 7.9QTRXQuanterix CorporationQOC 6.6QTIQT Imaging Holdings, Inc.QOC 5.6PFSAProfusa, Inc.QOC 4.1IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ITGR · LIVN · BVS · INFU · MDNC · GEHC · QTRX · QTI · PFSA · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to VMD?

7 companies across all industries closest to VMD’s Quality of Company score of 8.2/10.

SBLKStar Bulk Carriers Corp.QOC 8.2RCLRoyal Caribbean Cruises Ltd.QOC 8.2HDBHDFC Bank LimitedQOC 8.2MFINMedallion Financial Corp.QOC 8.1SGUStar Group, L.P.QOC 8.2LYFTLyft, Inc.QOC 8.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SBLK · RCL · HDB · MFIN · SGU · LYFT · NVDA

Where Does VMD Sit in CirclFi's Medical Devices Rankings?

VMD is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Viemed Healthcare, Inc.’s Valuation?

What is Viemed Healthcare, Inc.'s intrinsic value in 2026?

CirclFi puts Viemed Healthcare, Inc. (VMD)'s intrinsic value at $4.92 — the median of 12 independent model estimates as of 2026-08-28, ranging from $1.46 to $26.64. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $3.56 on its own. The Quality of Company score is 8.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is VMD overvalued or undervalued right now?

At $8.82, 4 of 12 active models suggest VMD may be undervalued, while 8 indicate potential overvaluation. The median of all 12 fair value estimates is $4.92, 44.2% below the current price of $8.82 — a consensus view that VMD is overvalued. The assessment depends on which methodology best fits Viemed Healthcare, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 8.2 mean for VMD?

Viemed Healthcare, Inc.'s QOC of 8.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on VMD?

CirclFi analyzes VMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on VMD?

Of the 12 models currently active on VMD, First Chicago is the most bullish at $26.64 per share, and Dynamic NAV is the most bearish at $1.46. CirclFi's published fair value for VMD is the median of that range, $4.92, not either extreme. The gap between the two ends equals 511% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is VMD a value trap in 2026?

Viemed Healthcare, Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 12-model valuation engine, Viemed Healthcare, Inc. (VMD) has a median fair value of $4.92 — 44.2% below the current price of $8.82 — as of 2026-08-28.” Source: circlfi.com/stock/VMD/ · Methodology
Primary sources for this VMD valuation
  • Financial statements: Viemed Healthcare, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001729149) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for VMD as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on VMD.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

8 models hidden for VMD Unlock All 12 — $39/mo